CTI Biopharma confirms a CRO is involved in Ph III trial halted after deaths
Adam Craig - President and Chief Executive Officer - CTI BioPharma Corp. | LinkedIn
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CTI BioPharma Corp.
Adam Craig - President and Chief Executive Officer - CTI BioPharma Corp. | LinkedIn
CEO Bianco retires after 25 years running profitless CTI BioPharma | The Seattle Times
CTI BioPharma's PRE-VENT Trial Misses Endpoint In Severe COVID | Contract Pharma
CTI BioPharma: A Speculative Buy Into The PDUFA Date (NASDAQ:CTIC) | Seeking Alpha
CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2022 Earnings Call Transcript
FDA approves CTI BioPharma's bone marrow cancer drug | Reuters
CTI BioPharma's pacritinib fails to meet primary goal in Covid study
CTI BioPharma | Targeted Blood Cancer Therapies | Home
CTI BioPharma settles with investors; Ex-CEO James Bianco faces new lawsuit over yacht - Puget Sound Business Journal
CTI BioPharma Corp Share Price Common Stock NPV
CTI BioPharma | Targeted Blood Cancer Therapies | Home
CTI BioPharma: Q4, Missed Earnings, But Compelling Progress In Market Launch | Seeking Alpha
